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Summary
Objective: Although most studies have focused on the cholesterol-lowering activity of stigmasterol, other bioactivities have been ascribed to
this plant sterol compound, one of which is a potential anti-inﬂammatory effect. To investigate the effects of stigmasterol, a plant sterol, on the
inﬂammatory mediators and metalloproteinases produced by chondrocytes.
Method: We used a model of newborn mouse chondrocytes and human osteoarthritis (OA) chondrocytes in primary culture stimulated with or
without IL-1b (10 ng/ml), for 18 h. Cells were pre-incubated for 48 h with stigmasterol (20 mg/ml) compared to untreated cells. We initially in-
vestigated the presence of stigmasterol in chondrocyte, compared to other phytosterols. We then assessed the role of stigmasterol on the
expression of various genes involved in inﬂammation (IL-6) and cartilage turn-over (MMP-3, -13, ADAMTS-4, -5, type II collagen, aggrecan)
by quantitative Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR). Additional experiments were carried out to monitor the produc-
tion of MMP-3 and prostaglandin E2 (PGE2) by speciﬁc immuno-enzymatic assays. We eventually looked at the role of stigmasterol on NF-kB
activation by western blot, using an anti-IkBa antibody.
Results: After 18 h of IL-1b treatment, MMP-3, MMP-13, ADAMTS-4, but not ADAMTS-5 RNA expression were elevated, as well as MMP-3
and PGE2 protein levels in mouse and human chondrocytes. Type II collagen and aggrecan mRNA levels were signiﬁcatively reduced. Pre-
incubation of stigmasterol to IL-1b-treated cells signiﬁcantly decreased these effects described above (signiﬁcant reduction of MMP-3 mRNA
in human and mouse, MMP-3 protein in mouse, MMP-13 mRNA in mouse and human, ADAMTS-4 mRNA in human, PGE2 protein in human
and mouse) Finally, stigmasterol was capable of counteracting the IL-1b-induced NF-kB pathway.
Conclusion: This study shows that stigmasterol inhibits several pro-inﬂammatory and matrix degradation mediators typically involved in
OA-induced cartilage degradation, at least in part through the inhibition of the NF-kB pathway. These promising results justify further
ex vivo and in vivo investigations with stigmasterol.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is a disease that results from a dysba-
lance between cartilage anabolism and catabolism. This dys-
balance is a result of the overexpression of pro-inﬂammatory
mediators (Interleukin-1 (IL-1)b, tumor necrosis factor (TNF),
prostaglandin E2 (PGE2), etc.) leading to the synthesis of
matrix-degrading enzymes such asmatrix metalloproteinase
(MMP) and a desintegrin and metalloproteinase with throm-
bospondin motifs (ADAMTS)1e6. The overexpression of cat-
abolic enzymes by pro-inﬂamatory mediators is mediated byaPresent address: NIH, NIAMS, CBOB, 50 South drive, Bethesda
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bAuthors with equal contribution.
*Address correspondence and reprint requests to: F. Berenbaum,
UR-4, UPMC Paris VI, 7 quai St Bernard, Paris 75005, France. Tel:
33-144-27-22-83; Fax: 33-144-27-51-40; E-mail: francis.beren-
baum@sat.aphp.fr
Received 25 March 2009; revision accepted 12 August 2009.
106a set of pro-inﬂammatory signaling pathways. Among them,
the activation of nuclear factor-kB (NF-kB)7, is critical in the
pathophysiology ofOA8,9. Thus, agents that suppress the ex-
pression of IL-1b, pro-inﬂammatory mediators, MMP or sup-
press the activation of NF-kB, have potential for the
treatment of OA.
Numerous agents derived from plants can suppress cell
signaling intermediates: Kasinski et al. have shown that an
analog of curcumin inhibits the NF-kB pathway10. Aggarwal
et al. have studied the inhibition of the NF-kB pathway by in-
hibiting cyclooxygenase-2 (Cox-2) and CyclinD1 protein pro-
duction, by other than non-steroidal anti-inﬂammatory agents
(NSAID) anti-inﬂammatory agents, as resveratrol or curcu-
min. Interestingly, these compounds are the most potent
anti-inﬂammatory and anti-proliferative agents of those they
studied11. Tea polyphenols inhibit IL-b stimulated MMP-1
and -13 through the NF-kB and activator protein (AP)-1 path-
ways in human chondrocytes12. Guggulsterone, a plant ste-
rol, inhibits NF-kB signaling by blocking Inhibitor of kappa B
(I-kB) kinase and ameliorates acute murine inﬂammation13.
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creases MMP-9 and COX-2 expression, inhibits the NF-kB
pathway, and reduces apoptosis in different cell lines14. It
is well known that all these factors play an important role in
arthritis.
Boswellic acid, an extract from boswellia resin, a major
anti-inﬂammatory agent in herbal traditional medicine, has
been shown to inhibit tumor necrosis factor (TNF)-alpha-
mediated NF-kB activation, but not c-Jun-Nterminal Kinase
(JNK) or p38 mitogen activated protein (MAP) kinases15.
The Indian ginseng, or Withania somnifera Dunal (Ashwa-
gandha), is used in ayurvedic medicine to treat arthritis or
inﬂammation. Ichikawa et al. have shown that Withanolides
inhibits NF-kB, IL-1b or TNF-alpha stimulated, as well as
COX-2 gene products in inﬂammation16. Boswellic acid
treatment in herbal traditional medicine, has a robust anti-in-
ﬂammatory effect in a mouse inﬂamed paw model15.
Phytosterols or plant sterols are fatty acids contained in
plants. Their chemical structure is very close to cholesterol,
the most common animal fatty acid. Little is known about
the role of phytosterols in cartilage, and their therapeutic
role in arthritis7. However, as soon as 1953, Thiers dis-
cussed the value of stigmasterol as an anti-stiffness factor
in the therapy of rheumatic diseases, as shown in guinea
pigs experiments17. After the administration of a compound
composed of three phytosterols, paw edema and neutrophil
inﬁltration were decreased in inﬂamed tissues, as well as
the level of superoxide ions, within an adjuvant-induced
arthritis mouse model18. Bouic et al. have tested runners
consuming beta-sitosterol and shown that some immuno-
parameters were increased while IL-6 was decreased in
the circulation, suggesting a lower inﬂammatory re-
sponse19,20. Given that phytosterols have a potent anti-
inﬂammatory effect, we investigated their effect on
chondrocyte metabolism in term of expression of inﬂamma-
tory and degradative markers.Material and methodsPRIMARY CELL CULTUREAll experiments were performed according to protocols approved by the
French/European ethics committee.
- Mouse cartilage was obtained after dissection of three different litters
of 12 newborn swiss mouse rib, 5e6 days old21,22. We obtained chon-
drocytes after digestion with collagenase D, 3 mg/mL (Roche Diagnos-
tics, Meylan, France) for 1 h 30 min at 37C in rotation and a following
overnight incubation at 0,5 mg/mL. Chondrocytes were grown to con-
ﬂuence in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM) 1 g/L glucose
(SigmaeAldrich, St Quentin-Fallavier, France) supplemented with 10%
foetal calf serum (Invitrogen, Eragny, France), 60 U/ml penicillin, 60 mg/
ml streptomycin and 2 mmol/l glutamine (Sigma) at 37C with 6% CO2.
In each experiment, cells were made quiescent for 24 h in DMEM me-
dium without serum and with bovine albumin fatty acid free (Sigma).
Cells were pre-incubated with 20 mg/mL of stigmasterol (Fluka, Sig-
maeAldrich, Germany), dissolved in ethanol during 48 h in DMEM
without serum. As a control, cells were incubated within the equivalent
volume of ethanol (0.1% ﬁnal). These compounds were maintained
during the whole period of incubation. Then, cells were stimulated
with or without rIL-1b, 10 ng/mL (PeproTech, Rocky Hill, NJ) for
0e10 min and for 18 h, in 10 cm plates in duplicate.
- Human osteoarthritic cartilage was obtained after total knee replace-
ment from three different human samples. The average age was 66
years, range 59e80 years. Cartilage was dissected into small fragments
and submitted to sequential enzymatic digestions with hyaluronidase,
pronase and collagenase adapted from Sanchez et al.23. Chondrocytes
were plated in DMEM (4.5 g/l glucose) (SigmaeAldrich, St Quentin-Fal-
lavier, France) supplemented with 10% foetal calf serum (Invitrogen,
Eragny, France), 100 U/ml penicillin, 0.1 mg/ml streptomycin, 2 mmol/l
L-glutamine (Sigma) at 37C with 6% CO2. Cells were made quiescent
for 24 h in DMEM medium without serum and with 2% bovine albumin
fatty acids free (Sigma). Cells were pre-incubated with 20 mg/ml ofstigmasterol, as previously described. Then, cells were stimulated
with or without human rIL-1b 10 ng/ml (PeproTech, Rocky Hill, NJ) dur-
ing 18 h in 10 cm plates in duplicate. Cells incubated with 0.1% ethanol
alone served as control.DETERGENT-RESISTANT MEMBRANES (DRM) PREPARATIONCholesterol, epicoprostanol (5beta-cholestan-alpha-ol), campesterol, stig-
masterol and beta-sitosterol were obtained from Sigma (Saint Quentin-Fal-
lavier, France). Analytical grade solvents were obtained from Aldrich. The
silylation reagent (Regisil þ10% TrimethylchloroSilane) was obtained
from Interchim (Montluc¸on, France).
DRM were prepared on ice according to the method of Bligh and Dyer24.
Brieﬂy, DRM were separated from detergent-solubilised membranes and
from soluble proteins by ultracentrifugation on a discontinuous (40, 35 and
5%) sucrose gradient (in a Beckman SW41 rotor). DRM were recovered in
fractions 4e6, at the interface between the 5% layer and the 30 or 35%
layer. After vigorous mixing, the 40% layer was considered to be the soluble
fraction. The fractions were mixed with six volumes of chloroform-methanol
2/1 (v/v) containing epicoprostanol as the internal standard. Lipids were par-
titioned in the lower chloroform phase after addition of saline. After transfer
and evaporation of chloroform, the esteriﬁed lipids were saponiﬁed by meth-
anolic potassium hydroxide. Released fatty acids were methyled by Boron
Triﬂuoride (BF3)-methanol in order to not interfere with the chromatographic
separation of silylated sterols. The sterols were extracted with cyclohexane
and silylated by Bis-trimethylsilsyl-triﬂuoroacetamide (BSTFA)e Trimethyl-
chlorosilane (TMCS) 10%. Analysis by gas chromatographyemass spec-
trometry (GCeMS): the derivatives of sterols were separated by GC
(HewlettePackard) on a medium polarity capillary column provided by
Restek (Evry, France). The temperature was maintained for 10 min at
285C. Injector and detector temperatures were at 260C. Helium was
used as the carrier gas. The mass spectrometer (HewlettePackard) in series
with the GC chromatograph was set up for detection of positive ions. Ions
were produced in the electron impact mode at 70 eV. The sterols were iden-
tiﬁed by the fragmentogram in the scanning mode and quantiﬁed by selec-
tive monitoring of the speciﬁc ions after normalisation with the internal
standard epicoprostanol and calibration with weighed standards. The ions
(m/z) used for analysis were: cholesterol, 458, 329; campesterol, 472,
382; stigmasterol, 484, 394 and beta-sitosterol, 486, 396.PREPARATION OF CYTOSOLIC EXTRACTSCytosolic extracts were obtained from culture cells. Chondrocytes were
washed in Phosphate Buffer Saline (PBS) and re-suspended in buffer TLB
(TriseHCl pH 7.6 20 mM; NaCl 150 mM; ethylenediaminetetraacetic acid
(EDTA) pH 8 2 mM; triton 1%; Glycerol 10%; complete 25; orthovanadate
2 mM) and homogenized at þ4C for 30 min. Then, cells were vortexed
and centrifugated at 13,000 g for 10 min at þ4C. The cytosolic fractions
(supernatants) were separated and stored at 80C until analysis. Protein
concentration was determined by the bicinchoninic acid assay kit (BCA
Pierce, Interchim, Montluc¸on, France), according to the manufacturers
instructions.WESTERN-BLOT ANALYSISFor IkBa, cytosolic fractions were obtained as described above. Then,
similar amounts of proteins (10 mg) were run on Sodium dodecyl Sulfate
(SDS)-polyacrylamide gel by electrophoresis and were transferred to poly-
vinylidene diﬂuoride membranes (PVDF) with kaleidoscope prestained stan-
dards (Bio-Rad Ivry sur Seine, France). Membranes were blocked in
0.1 mmol/l Tris, pH 7.6, and 0.1 mmol/l NaCl containing 0,1% Tween-20
and 5% dry skimmed milk or bovine serum albumin (BSA) for 60 min at
room temperature. Then, membranes were incubated overnight with anti-
IkBa antibody (Santa Cruz, Tebu-bio, Le Perray en Yvelines, France) at
4C. After washing, detections were made by incubation with peroxidase-
conjugated secondary antibodies and developed by an enhanced chemilu-
miniscence kit (ECL, Amersham, Pharmacia biotec, Orsay, France), and
exposed to Kodak Biomax mRNA (MR)-1 ﬁlms. In order to ensure that
equal amounts of total proteins were loaded, we also hybridized each
membrane with anti-b-actin (SigmaeAldrich, St Quentin-Fallavier, France).RNA EXTRACTION AND REVERSE TRANSCRIPTASE-
POLYMERASE CHAIN REACTION (RT-PCR)Total RNA was extracted from each sample using the RNeasy Mini Kit
(Qiagen,GmbH, Hilden, Germany), according to the manufacturer’s instruc-
tions. A DNAse digestion step (RNAse free DNAse set, Qiagen) was added.
RNA concentration was then measured using a spectrophotometer. The mi-
gration in an agarose gel enabled quality control. Total RNA (1 mg) was
108 O. Gabay et al.: Stigmasterol in Osteoarthritis (OA)reverse transcribed with Omniscript Kit (Qiagen GmbH, Hilden, Germany) in
a ﬁnal volume of 20 mL containing 50 ng of oligos dT. The enzyme was then
inactivated by heating and the cDNAs of interest (hypoxanthine-guanine
phosphoribosyltransferase (HPRT), MMP-1, MMP-3, MMP-13, ADAMTS-4,
ADAMTS-5, IL-6) were quantiﬁed by real-time quantitative PCR using the
LC480 LightCycler* RT-PCR (Roche) and Fast Start DNA master plus regis-
tred (SYBR green) kits (Roche). Sense and antisense PCR primers were de-
signed by the LightCycler probe design*software, based on mouse and
human sequence information (Table I). The PCR reactions were performed
in a 12 ml ﬁnal volume using 0.2 ml of cDNA or, 600 ng of speciﬁc primers
and 1 Fast Start DNA master plus SYBR mixture (Roche). PCR ampliﬁca-
tion conditions were as follows: initial denaturation for 5 min at 95C followed
by 40 cycles consisting of 10 s at 95C, 15 s at 60C and 10 s at 72C. The
generation of speciﬁc PCR products was conﬁrmed by melting-curve analy-
sis. For each real-time RT-PCR run, cDNAs were run in triplicate in parallel
with serial dilutions of a puriﬁed DNA standard (from 106 to 103 copies) for
each primer pair to generate a linear standard curve, which was used to es-
timate relative quantities of genes of interest normalized for HPRT in the
sample.PGE2 ASSAYPGE2 production was measured in the media by a high sensitivity enzyme
immuno-assay kit (EIA, Cayman chemical, Ann Arbor, MI, USA) according to
the manufacturer’s instructions. The limit of detection was 9 pg/ml. PGE2
concentration was analysed at serial dilutions in duplicate and read against
standard curve.MMP-3 PROTEIN ASSAYMMP-3 protein production was measured in the media by an enzyme
linked immunoabsorbant assay (ELISA) (Mouse or Human MMP-3 total
Quantikine Immuno-assay, R&D systems Minneapolis, Minnesota)Table
Sequences of primers for the quan
Human gene Sense
HPRT F TGTAA
R CCAGT
MMP-3 F CCCAA
R 50GGGT
MMP-13 F CAACG
R ACAGA
ADAMTS-4 F 50AGAA
R 50GCGT
ADAMTS-5 F 50ATCA
R 50AGCA
IL-6 F 50CAAT
R 50GCAC
AGG F 50TCTA
R 50GGAA
Col2 F 50GGAT
R 50TTGG
Mouse gene Sense
HPRT F AGG AC
R ATT CA
MMP-3 F ATG AA
R GCA GA
MMP-13 F TGA TG
R TGT AG
ADAMTS-4 F 50GGC
R TCA GC
ADAMTS-5 F TCA GC
R CCA GG
IL-6 F GTC AC
R AGA GA
AGG F 50CAGA
R 50AGAC
Col2 F 50GGC
R 50ATG Gaccording to the manufacturer’s instructions. MMP-3 concentration were
analysed in triplicate.BIOCHEMICAL ANALYSIS: MEASUREMENT OF LACTATE
DESHYDROGENASE (LDH)Cell mortality is evaluated by measurement of LDH in the supernatant of
the cultures. Fifty microliters of buffer Tris 10 mM, pH 8.5, containing 10 mg/
ml of bovine serum albumin were mixed with 100 ml of standard or samples
(before freezing). Then, 50 ml of reaction mix, composed by piodonitrotetra-
zolium violet (1.6 mg/ml) nicotinamide-adenine-dinucleotide (4 mg/ml) and
phenazine methosulphate (0.4 mg/ml) was added. After 10 min incubation
at room temperature, absorbance was read at 492 nm. A standard curve
was obtained using LDH isolated from rabbit muscle at a concentration rang-
ing from 12.5 to 2000 ng/ml. Percent of dead cells was calculated using fol-
lowing formula: (LDH of culture medium/total LDH) 100. (BSA,
piodonitrotetrazolium and Molecular weight (PM) are from SigmaeAldrich,
Bornem, Belgium; Nicotinamide Adenine Dinucleotide (NAD) and LDH iso-
lated from rabbit muscle are from Roche pharmaceuticals, Brussels,
Belgium).STATISTICAL ANALYSISResults are expressed as the mean and standard deviation (SD). All anal-
ysis were performed with Prism (Prism, GraphPad Software Inc, San Diego,
CA).
The mean and SD of two populations were compared with unpaired
t tests, assuming unequal variances. For multiple comparisons, depending
on the experiment, one way or two ways analysis of variance (ANOVA)
were performed before posttests, assuming Gaussian distribution.
For % of inhibition on Western Blot ﬁlms, we used Genesnap and Gene-
tools software, in the syngene system (Cambridge, UK). We previously as-
signed 100% of intensity to the controls, and the device calculated the %
of intensity of the other bands, compared to controls.I
titative RT-PCR experiments
Sequence 50 / 30 Size (pb)
TGACCAGTCAACAGGG 104
GTCAATTATATCTTCCACAATC
GAGGCATCCAC 264
CAAACTCCAACTGT
GACCCATACAG 376
CCATGTGTCCC
GAAGTTTGACAAGTGC 225
GTATTCACCATTGAG
CCCAATGCCAAGG 246
GAGTAGGAGACAAC
GAGGAGACTTGCCTGG 113
AGCTCTGGCTTGTTCC
CCTCTGCGGTAGGG 154
GTTCACTGACATCCTCTAT
GCCACACTCAAG 216
GGTAGACGCAAG
Sequence 50 / 30 Size (pb)
C TCT CGA AGT GT 111
A ATC CCT GAA GTA CTCAT
A ATG AAG GGT CTT CCG G 108
A GCT CCA TAC CAG CA
G CAC TGC TGA CAT CAT 173
C CTT TGG AAC TGC TT
AAG GAC TAT GAC GC 155
C CAA GGT GAG TG
C ACC ATC ACA GAA 161
G CAC ACC GAG TA
A GAA GGA G5G GCTA 193
A CAA CAT AAG TCA GAT ACC
TTAGTGGAGGGTGTGA 152
CCTGGGAAGTTTGT
AAC AGC AGG TTC ACA TA 131
GT GCG ATG TCA ATA AT
109Osteoarthritis and Cartilage Vol. 18, No. 1All western blots were repeated three times to verify consistency. The rep-
resentative results are presented in ﬁgures.ResultsSTIGMASTEROL BINDS TO THE CHONDROCYTE MEMBRANE
DRM (DETERGENT RESISTANT MEMBRANE) AT A HIGHER
LEVEL COMPARED TO SITOSTEROL AND CAMPESTEROLWhen chondrocytes were pre-incubated with the same
amount of the three phytosterols (20 mg/ml) i.e., stigmas-
terol, sitosterol and campesterol, they were found upon
chondrocyte membranes in different amount, bind to the
chondrocyte membrane [Fig. 1(A)]. Stigmasterol was able
to bind the membrane at a higher level than the two othersSo
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Fig. 1. (A) Stigmasterol is preferentially found in chondrocyte membranes
were cultured and grown to conﬂuence and serum starved from 24 h follo
bation during 48 h. At the end of the incubation, cells were washed and c
break the cell membranes and analysed by mass spectrometry after lipid
from two independent experiments. A two ways ANOVA was perfo
***P< 0.0001. (B) Stigmasterol is found in lipid rafts of chondrocyte mem
ﬂuence and serum starved from 24 h followed by 20 mg/ml stigmasterol p
washed and collected to 250 ml of PBS. This homogenate was sonica
mass spectrometry. Analysis was then carried out according to M&M. Th
pendent experiments One way ANOVA was performed before posttests (
with the soluble group (fract.(2-fold compared to campesterol, and 1.8-fold compared to
sitosterol). When pre-incubated alone, stigmasterol is found
in 74% of chondrocyte DRM (data not shown), and more
particularly in fractions 4e6, insoluble membranes or lipid
rafts, obtained after sucrose gradient extraction from the
method described by Bligh and Dyer24 Fractions 4, 5 and
6 are established as detergent resistant membranes known
as lipid rafts, and fractions 711 as soluble membranes
[Fig. 1(B)].
On a western blot performed with the same fractions, us-
ing an anti Cav 1 antibody (Mouse Anti-Caveolin-1 Mono-
clonal Antibody, Clone 2297. BD Biosciences) we found
Caveolin-1 protein in fraction 4, 5 and 6 (data not shown).
After identifying that stigmasterol had a better afﬁnity to
bind chondrocyte membranes, we carried outSo
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as compared to three different sterols. Mouse costal chondrocytes
wed by 20 mg/ml stigmasterol, campesterol or sistosterol pre-incu-
ollected to 250 ml of PBS. This homogenate is sonicated in order to
extraction. This graph represents the mean and the SD obtained
rmed before posttests (Bonferroni multiple comparison test),
brane. Mouse costal chondrocytes were cultured and grown to con-
re-incubation during 48 h. At the end of the incubation, cells were
ted to disrupt the cell membrane and was following subjected to
e graph represents the mean and the SD obtained from three inde-
ManneWhitney test) We compared the insoluble group (fract. 4e6)
7e11). ***P¼ 0.0007.
110 O. Gabay et al.: Stigmasterol in Osteoarthritis (OA)a concentration-dependent incubation with this sterol, rang-
ing from 0 to 80 mg/ml (0, 10, 20, 40, 60, 80 mg). Forty mg/ml
represented the maximum dose for stigmasterol binding in
chondrocyte. This amount of stigmasterol in chondrocyte
did not affect the amount of membrane cholesterol as mea-
sured by mass spectrometry. Additionally, none of the con-
centrations affected cell viability, as determined by LDH
assay (data not shown). We have then chosen to study
the role of stigmasterol at the concentration of 20 mg/ml in
chondrocyte.
To reproduce inﬂammation conditions, we stimulate our
cell culture with IL-1b (10 ng/ml) during 18 h after pre-incu-
bation of stigmasterol during 48 h.IL-1b STIMULATED PGE2 RELEASEIL-1b stimulation (10 ng/ml) for 18 h leads to an increase
of PGE2 release of 151-fold in human chondrocytes
(P< 0.0001), and 18-fold in mouse chondrocytesCo
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Fig. 2. (A) Stigmasterol inhibits PGE2 release after IL-1b stimulation in mo
conﬂuence and serum starved from 24 h followed by 20 mg/ml stigmaste
(10 ng/ml) was added in the culture media, for 18 h. This graph represents
performed in duplicate. Results are expressed in pg/ml. The mean and th
assuming unequal variances. **P¼ 0.0016 and *P¼ 0.0177. (B) Stigmast
cytes. Human chondrocytes were cultured and grown to conﬂuence and
cubation during 48 h. At the end of the incubation, IL-1b (10 ng/ml) wa
mean and the SD of data from three independent experiments performe
SD of the two populations were compared with unpaired t tests, assuming
inhibits basal PGE2 production in a concentration-dependent manner. Hum
starved from 24 h followed by a range of increased concentrations, in mg
graph represents the mean and the SD of data from three independent e
pressed in ng/mg of DNA; One way ANOVA was perform(P< 0.001). When stigmasterol (20 mg/ml) is pre-incubated
for 48 h in starving conditions before IL-1b treatment, the ef-
fect of IL-1b on PGE2 production is decreased by 2-fold in
human chondrocytes (P¼ 0.001) and 1.3-fold in mice chon-
drocytes (P< 0.05) [Fig. 2(A, B)].
When stigmasterol is increased in concentration (5, 10,
20, 40, 80 mg/ml) and pre-incubated for 48 h, basal PGE2
production is decreased until 2-fold in human chondro-
cytes (P< 0.05) in a concentration-dependent manner
[Fig. 2(C)].STIGMASTEROL DECREASES IL-1b STIMULATED MMP-3 GENE
EXPRESSION AND PROTEIN PRODUCTIONStimulation with IL-1b (10 ng/ml) for 18 h leads to 26-fold
increase of MMP-3 gene expression in mouse (P< 0.0001),
and 3.3-fold increase in human chondrocytes (P¼ 0.0362).
When stigmasterol (20 mg/ml) is pre-incubated during 48 h
before the IL-1b treatment, MMP-3 gene expression de-
creases by 6-fold in mouse chondrocytes (P< 0.0001)Co
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Fig. 3. Stigmasterol inhibits MMP-3 gene expression and MMP-3 protein release after IL-1b stimulation in mouse chondrocytes, and MMP-3
gene expression in human chondrocytes. (A) MMP-3 gene expression was decreased in presence of stigmasterol and IL-1b. Mouse chon-
drocytes were cultured and grown to conﬂuence and serum starved from 24 h followed by 20 mg/ml stigmasterol pre-incubation during
48 h. At the end of the incubation, IL-1b (10 ng/ml) was added in the culture media, for 18 h. This graph represents the mean and the SD
of data from three different experiments performed in duplicate. Results are expressed as a ratio between MMP-3 mRNA and HPRT (an house
keeping gene) mRNA. The mean and the SD of the two populations were compared with unpaired t tests, assuming unequal variances.
***P< 0.0001 and ***P¼ 0.001. (B) MMP-3 gene expression was decreased in presence of stigmasterol and IL-1b. Human chondrocytes
were cultured and grown to conﬂuence and serum starved from 24 h followed by 20 mg/ml stigmasterol pre-incubation during 48 h. At the
end of the incubation, IL-1b (10 ng/ml) was added in the culture media, for 18 h. This graph represents the mean and the SD of data from
three different experiments performed in duplicate. Results are expressed as a ratio between MMP-3 mRNA and HPRT (a house keeping
gene) mRNA. The mean and the SD of the two populations were compared with unpaired t tests, assuming unequal variances.
*P¼ 0.0362 and *P¼ 0.0493. (C) Stigmasterol inhibits MMP-3 protein release after IL-1b stimulation in mouse chondrocytes. Mouse chondro-
cytes were cultured and grown to conﬂuence and serum starved from 24 h followed by 20 mg/ml stigmasterol pre-incubation for 48 h. At the
end of the incubation, IL-1b (10 ng/ml) was added in the culture media, during 18 h. This graph represents the mean and the SD of data from
three independent experiments performed in duplicate. Results are expressed in ng/ml. The mean and the SD of the two populations were
compared with unpaired t tests, assuming unequal variances. *P¼ 0.0109 and *P¼ 0.0176. (D) Stigmasterol has no effect on MMP-3 protein
release after IL-1b stimulation in human chondrocytes. Human chondrocytes were cultured and grown to conﬂuence and serum starved from
24 h followed by 20 mg/ml stigmasterol pre-incubation for 48 h. At the end of the incubation, IL-1b (10 ng/ml) was added in the culture media,
during 18 h. This graph represents the mean and the SD of data from three independent experiments performed in duplicate. Results are ex-
pressed in ng/ml. The mean and the SD of the two populations were compared with unpaired t tests, assuming unequal variances.
*P¼ 0.0394 and P¼ 0.118, Not Signiﬁcant (NS).
111Osteoarthritis and Cartilage Vol. 18, No. 1and by 4.5-fold in human chondrocytes (P¼ 0.0493)
[Fig. 3(A, B)].
IL-1b stimulation (10 ng/ml) during 18 h leads to a 14-fold
increase of MMP-3 release in the media of mouse chondro-
cytes (P¼ 0.0109) and 1.6-fold increase in the media ofhuman chondrocytes (P¼ 0.0394). However, when stig-
masterol (20 mg/ml) is pre-incubated for 48 h before IL-1b
treatment, IL-1b stimulated MMP-3 production was de-
creased by 4.25-fold in mouse (P¼ 0.0176) but not signiﬁ-
cantly in human [Fig. 3(C, D)].
112 O. Gabay et al.: Stigmasterol in Osteoarthritis (OA)STIGMASTEROL DECREASES MMP-13 GENE EXPRESSION
FOLLOWING IL-1b STIMULATIONStimulation with IL-1b (10 ng/ml) for 18 h leads to a 6-fold
increase of MMP-13 gene expression in mouse chondro-
cytes (P¼ 0.0071) and 34-fold increase in human chondro-
cytes (P< 0.001). Upon addition of stigmasterol (20 mg/ml)
during 48 h before the IL-1b treatment, MMP-13 gene ex-
pression is decreased by 7-fold in mouse (P¼ 0.0009)
and by 4-fold in human chondrocytes (P¼ 0.0187)
[Fig. 4(A, B)].STIGMASTEROL DECREASES ADAMTS-4 GENE EXPRESSION
FOLLOWING IL-1b STIMULATION, BUT ADAMTS-5 GENE
EXPRESSION IS UNAFFECTED BY BOTH IL-1b STIMULATION
OR STIGMASTEROL PRE-INCUBATIONStimulation with IL-1b (10 ng/ml) for 18 h leads to a 2.5-
fold increase of ADAMTS-4 gene expression in mouse (NS)
and 3-fold increase in human chondrocytes (P< 0.0001).
When stigmasterol (20 mg/ml) was pre-incubated during
48 h before the IL-1b treatment, ADAMTS-4 gene expression
was decreased by 1.8-fold in mouse chondrocytes
(P¼ 0.0156), and by 4.2-fold in human chondrocytes
(P< 0.0001).
However, mouse RNA levels of ADAMTS-5 were unaf-
fected nor by IL-1b stimulation, nor by stigmasterol incuba-
tion before IL-1b stimulation, as compared to untreated
controls. The same proﬁle was observed in human chondro-
cytes [Fig. 5(B, D)].STIGMASTEROL HAD NO EFFECT ON IL-6, AGGRECAN AND
COL2 GENE EXPRESSION IN CHONDROCYTESIL-1bstimulation (10 ng/ml) during18 h lead toa256-fold in-
crease of IL-6 gene expression in mouse chondrocytes and
a 20-fold increase in human chondrocytes. Pre-incubation ofCo
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Fig. 4. Stigmasterol inhibits IL-1b stimulated MMP-13 gene expression i
cultured and grown to conﬂuence and serum starved from 24 h followed
the incubation, IL-1b (10 ng/ml) was added in the culture media, for 18 h.
dependent experiments performed in duplicate. Results are expressed as
the SD of the two populations were compared with unpaired t tests, assum
chondrocytes were cultured and grown to conﬂuence and serum starved
48 h. At the end of the incubation, IL-1b (10 ng/ml) was added in the cu
of data from three independent experiments performed in duplicate. Res
mRNA. The mean and the SD of the two populations were compared w
and *P¼ 0.stigmasterol (20 mg/ml) during 48 h to IL-1b stimulated cells
did not affect gene expression levels of IL-6 gene expression
compared to the same culture IL-1b stimulated in mouse or
human chondrocytes (data not shown).
When cells were stimulated with IL-1b (10 ng/ml), a 7.3-
fold decrease of aggrecan and a 4-fold decrease of Col2
gene expression was observed in mouse chondrocytes.
However stigmasterol (20 mg/ml) pre-incubation with IL-1b
did not affect these RNA levels, compared to controls stim-
ulated with IL-1b alone. The same proﬁle was observed in
human chondrocytes (data not shown).STIGMASTEROL INHIBITS I-kB DEGRADATION FOLLOWING
IL-1b STIMULATIONTreatment of mouse chondrocytes with IL-1b (10 ng/ml)
caused a rapid inhibition of cytosolic I-kBa expression,
from 7 min (2.6-fold, P< 0.0001) to 10 min (3.2-fold,
P< 0.0001) post IL-1b exposure. This effect on I-kBa ex-
pression was reversed when stigmasterol was pre-incu-
bated during 48 h before IL-1b stimulation (20 mg/ml) at 7
and 10 min (P< 0.0001) [Fig. 6(A, B)].Discussion
The previous interest of examining the action of phytos-
terols on cardiovascular diseases lead to seek the potent
anti-inﬂammatory properties of these compounds25e29.
But little is known concerning the impact of these com-
pounds in arthritis7.
The ﬁrst pharmacological question was to conﬁrm that
phytosterols were able to bind to chondrocytes; we used
an original approach consisting of analysing by mass spec-
trometry, after obtaining chondrocyte homogenate following
phytosterol incubation. Campesterol, sitosterol and stig-
masterol are the main components of a great variety ofCo
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Fig. 5. ADAMTS-4 gene expression is inhibited by stigmasterol in human chondrocytes. (A) Mouse chondrocytes were cultured and grown to
conﬂuence and serum starved from 24 h followed by 20 mg/ml stigmasterol pre-incubation during 48 h. At the end of the incubation, IL-1b
(10 ng/ml) was added in the culture media, during 18 h. This graph represents the mean and the SD of data from three independent exper-
iments performed in duplicate. Results are presented as a ratio between ADAMTS-4 mRNA and HPRT mRNA. The mean and the SD of the
two populations were compared with unpaired t tests, assuming unequal variances. P¼ 0.103, NS and *P¼ 0.0156 [Fig. 5(A)]. (B) Stigmas-
terol has no effect on ADAMTS-5 gene expression in mouse or human chondrocytes. Mouse [Fig. 5(B)] or human [Fig. 5(D)] chondrocytes
were cultured and grown to conﬂuence and serum starved from 24 h followed by 20 mg/ml stigmasterol pre-incubation during 48 h. At the
end of the incubation, IL-1b (10 ng/ml) was added in the culture media, during 18 h. This graph represents the mean and the SD of data
from three independent experiments performed in duplicate. Results are presented as a ratio between ADAMTS-5 mRNA and HPRT
mRNA. The mean and the SD of the two populations were compared with unpaired t tests, assuming unequal variances. (C) Human chon-
drocytes were cultured and grown to conﬂuence and serum starved from 24 h followed by 20 mg/ml stigmasterol pre-incubation during 48 h. At
the end of the incubation, IL-1b (10 ng/ml) was added in the culture media, during 18 h. This graph represents the mean and the SD of data
from two independent experiments performed in duplicate. Results are presented as a ratio between ADAMTS-4 mRNA and HPRT mRNA.
The mean and the SD of the two populations were compared with unpaired t tests, assuming unequal variances. ***P< 0.0001 and
***P< 0.001.
113Osteoarthritis and Cartilage Vol. 18, No. 1plants and generally found together. Plat et al. found a pref-
erential incorporation of campesterol in various tissues32.
But very little has been done to compare the potential effect
of three sterols on a speciﬁc tissue. Furthermore, we looked
at the presence of the phytosterols upon the cell membrane,
assessed by mass spectrometry after lipid extraction and to
obtain two parts of the cell membrane, the soluble fraction
and the detergent resistant membrane or DRM. We also ex-
tracted the membrane lipids on a sucrose gradient as de-
scribed by Bligh and Dyer24, to obtain different fractions,including the lipid rafts (fractions 4, 5, 6) Fraction 11 is con-
stituted by the cytoskeleton and the part of the membrane
still bound to it. Lipid rafts are dynamic microdomains of
the membrane, rich in cholesterol and sphingolipids33.
Indeed, we have found a great amount of stigmasterol in
DRM and lipid rafts of the chondrocyte membranes. We
have additionally conﬁrmed the presence of Caveolin-1,
a lipid raft marker, in the fractions containing stigmasterol,
by western blot (data not shown). Lipid rafts are known to
be the ‘‘signaling platform’’ of the cell33 and many receptors
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Fig. 6. I-kB expression in chondrocytes. (A) The IL-1b-induced inhibition of cytosolic I-kBa expression is counteracted by stigmasterol in costal
chondrocytes. Mouse chondrocytes were cultured and grown to conﬂuence and serum starved for 24 h followed by 20 mg/ml stigmasterol pre-
incubation during 48 h. Then, cells were incubated in presence or absence of IL-1b (10 ng/ml) for 0e10 min. Cytosolic extracts were electro-
phorezed under reducing, denaturing conditions, stained with afﬁnity-puriﬁed anti-I-kBa antibody and bactin, and visualized by enhanced
chemiluminiscence. The ﬁgure presents data from one of three independent experiments that produced similar results. (B) Quantiﬁcation
of results presented in A. A one way ANOVA was performed before posttests (Bonferroni multiple comparison test) ***P< 0.0001. The values
were obtained after normalizing the band intensity to beta-actin.
114 O. Gabay et al.: Stigmasterol in Osteoarthritis (OA)are detected in these parts of the cell membranes, such as
cytokine receptors, glucocortico€ıds receptors or integrins.
Lipid rafts act like a platform of recruitment for different pro-
teins33. Sebald et al. have studied NF-kB and shown that all
the members of the NF-kB family, included I-kappa B
Kinase (IKK), are found constitutively and inductively in lipid
rafts. NF-kappa B Inducing Kinase (NIK) seems to be the
ﬁrst kinase involved in the complex bound to the rafts34.
This could explain the mechanism by which stigmasterol
acts and its potential involvement in signaling pathways,
like the NF-kB pathway.
Aggrecanase 1 and aggrecanase 2, known as ADAMTS-4
and ADAMTS-5, have been shown to be involved in aggre-
can degradation in the extra-cellular matrix (ECM)35.
ADAMTS-4 is induced by IL-1b and ﬁbronectin fragments35.
ADAMTS-5 is constitutively expressed in cartilage, and is
found to be increased in OA patients6, conﬁrming its key
role in this pathology. ADAMTS-5 knock-out mice prevent
cartilage degradation in an experimental model of OA36. It
has been shown that aggrecan loss from mouse cartilage is
predominantly because of ADAMTS-5 activity37. That is the
reason why it is commonly admitted that IL-1b regulates dif-
ferently ADAMTS in human and mouse. ADAMTS-4 seemsto be regulated by IL-1b in human38. But Koshy et al. have
shown that there is a synergistic induction of geneexpression
of both ADAMTSby IL-1b39,40. In ourmodel, our results show
that ADAMTS-4 is induced by IL-1b in human, whereas
ADAMTS-5 is constitutively expressed in both species, and
does not vary in presence of IL-1b. We could hypothesize
that ADAMTS-5, which is constitutively expressed in carti-
lage, acts synergistically with ADAMTS-4 only when the OA
process is enhanced. Moreover, we show that stigmasterol
plays a role in reducing IL-1b-induced ADAMTS-4 gene
expression in both species.
We expected, in our model, to have a beneﬁcial action of
stigmasterol on loss of aggrecan and type II collagen, at
a RNA level. After studying these two factors, we did not
see any difference in mouse chondrocytes. However, we
did not perform the same experiments in human chondro-
cytes. Maybe the incubation with stigmasterol should be
longer to see any effect on a reduction of ADAMTS-4-IL-
1b stimulated mRNA. It could be the same concerning Col-
lagen 2 mRNA.
IL-6 is a pro-inﬂammatory cytokine which plays a syner-
gistic effect with IL-1b in several inﬂammatory processes41.
Our results show an 256-fold increase of IL-6 production
115Osteoarthritis and Cartilage Vol. 18, No. 1after IL-1b stimulation in mouse and an 20-fold increase in
human chondrocytes. However, no variation of IL-6 expres-
sion was observed after a pre-incubation with stigmasterol
(data not shown) This lack of efﬁciency with stigmasterol
is surprising, because IL-6 seems to act together with IL-
1b and should be affected by stigmasterol as IL-1 is. How-
ever, so far some publication have been shown that IL-6
cross talk with transforming growth factor (TGF)-b42 and
have been shown to be an important inhibitor of cell
death43. In our model, IL-6 could play as well a different
role as an inﬂammatory cytokine, as IL-1b, that could be
the reason why it is not affected by stigmasterol.
The question remains: could stigmasterol penetrate carti-
lage? We previously described, in another publication, that
cartilage explants incubated during 48 h with a compound
rich in phytosterols, shows salient effects on inﬂammatory
mediators and pro-degrading enzymes, as well as on signal-
ing pathways involved in inﬂammation30 The compound
seems to penetrate into the cartilage (at last into the superﬁ-
cial zone) after 48 h incubation. Cartilage explants incubation
with stigmasterol in the sameconditions could result in similar
effects. In this work, we saw that phytosterols (stigmasterol,
campesterol, sitosterol) are able to bind chondrocytes mem-
branes and are found in great amount in chondrocytes ho-
mogenates after 48 h stigmasterol incubation.
In conclusion, our work shows that stigmasterol is a plant
sterol able to bind to chondrocyte membrane and pos-
sesses potential anti-inﬂammatory and anti-catabolic prop-
erties. Stigmasterol counteracts the expression of the
MMPs involved in cartilage degradation along with an inhib-
itory effect on the pro-inﬂammatory mediator PGE2, at least
in part via the inhibition of the NF-kappa B pathway. Thus,
stigmasterol, by preventing the expression of deleterious
mediators should be considered as a target if future in
vivo experiments conﬁrm these in-vitro data. However,
more in-vitro experiments are needed to complete these
preliminary results.Conﬂict of interest
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